{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:43:07Z","timestamp":1793158987062,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bioactmat.2026.02.058","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T14:09:25Z","timestamp":1772633365000},"page":"34-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Dual-function oral nanotherapeutic mitigates sepsis-like multi-organ failure by targeting inflammatory and fibrotic pathways"],"prefix":"10.1016","volume":"62","author":[{"given":"James","family":"Asenso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7264-0002","authenticated-orcid":false,"given":"Neha","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghu","family":"Ganugula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0902-2470","authenticated-orcid":false,"given":"Tyler","family":"Posey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5606-401X","authenticated-orcid":false,"given":"M.N.V.","family":"Ravi Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bioactmat.2026.02.058_bib1","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","article-title":"The immunology of sepsis","volume":"54","author":"van der Poll","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.02.058_bib2","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.1038\/s41467-025-62788-6","article-title":"A citrullinated histone H3 monoclonal antibody for immune modulation in sepsis","volume":"16","author":"Ouyang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.02.058_bib3","first-page":"71","article-title":"An olsalazine nanoneedle-embedded inulin hydrogel reshapes intestinal homeostasis in inflammatory bowel disease","volume":"33","author":"Zhang","year":"2024","journal-title":"Bioact. Mater."},{"issue":"2017","key":"10.1016\/j.bioactmat.2026.02.058_bib4","first-page":"1","article-title":"Sepsis and immunosenescence in the elderly patient: a review","volume":"4","author":"Mart\u00edn","year":"2017","journal-title":"Front. Med."},{"issue":"6","key":"10.1016\/j.bioactmat.2026.02.058_bib5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.33696\/immunology.5.183","article-title":"Molecular pathways in sepsis pathogenesis: recent advances and therapeutic avenues","volume":"5","author":"Addissouky","year":"2024","journal-title":"J. Cell. Immunol."},{"key":"10.1016\/j.bioactmat.2026.02.058_bib6","doi-asserted-by":"crossref","first-page":"155707","DOI":"10.1016\/j.phymed.2024.155707","article-title":"Naringin: a flavanone with a multifaceted target against sepsis-associated organ injuries","volume":"130","author":"Bajgai","year":"2024","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.bioactmat.2026.02.058_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/CCM.0000000000002074","article-title":"Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome","volume":"45","author":"Mira","year":"2017","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bioactmat.2026.02.058_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fimmu.2015.00223","article-title":"Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability","volume":"6","author":"de Punder","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.02.058_bib9","article-title":"The role of lipopolysaccharide-induced cell signalling in chronic inflammation","volume":"6","author":"Page","year":"2022","journal-title":"Chronic Stress (Thousand Oaks)"},{"issue":"2","key":"10.1016\/j.bioactmat.2026.02.058_bib10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2741\/S405","article-title":"Causes and consequences of low grade endotoxemia and inflammatory diseases","volume":"5","author":"Glaros","year":"2013","journal-title":"Front. Biosci. (Schol Ed)"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.02.058_bib11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13054-023-04507-5","article-title":"Time to treatment and mortality for clinical sepsis subtypes","volume":"27","author":"Yang","year":"2023","journal-title":"Crit. Care"},{"key":"10.1016\/j.bioactmat.2026.02.058_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.phymed.2017.12.021","article-title":"Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability","volume":"40","author":"Singh","year":"2018","journal-title":"Phytomedicine"},{"issue":"39","key":"10.1016\/j.bioactmat.2026.02.058_bib13","doi-asserted-by":"crossref","first-page":"45651","DOI":"10.1021\/acsami.3c09866","article-title":"Rationally designed naringenin-conjugated polyester nanoparticles enable folate receptor-mediated peroral delivery of insulin","volume":"15","author":"Heyns","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"32","key":"10.1016\/j.bioactmat.2026.02.058_bib14","doi-asserted-by":"crossref","first-page":"eadw1358","DOI":"10.1126\/sciadv.adw1358","article-title":"Dual-function polyester nanoparticles for amplified anti-inflammatory effects","volume":"11","author":"Heyns","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2026.02.058_bib15","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2147\/IJN.S155593","article-title":"Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases","volume":"13","author":"Ganesan","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.bioactmat.2026.02.058_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejpb.2017.04.013","article-title":"Surface modification of solid lipid nanoparticles for oral delivery of curcumin: improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake","volume":"117","author":"Baek","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.bioactmat.2026.02.058_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1208\/s12249-019-1337-8","article-title":"Potential of lipid nanoparticles (SLNs and NLCs) in enhancing oral bioavailability of drugs with poor intestinal permeability","volume":"20","author":"Talegaonkar","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioactmat.2026.02.058_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.22203\/eCM.v053a01","article-title":"Matrine nanoparticles improve functional constipation and associated depressive behavioral disorders by modulating the gut-brain axis","volume":"53","author":"Liu","year":"2025","journal-title":"Eur. Cell. Mater."},{"issue":"21","key":"10.1016\/j.bioactmat.2026.02.058_bib19","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1021\/jacs.6b13231","article-title":"Next generation precision-polyesters enabling optimization of ligand\u2013receptor stoichiometry for modular drug delivery","volume":"139","author":"Ganugula","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.02.058_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1021\/acsmacrolett.7b00035","article-title":"Noncompetitive active transport exploiting intestinal transferrin receptors for oral delivery of proteins by tunable nanoplatform","volume":"6","author":"Ganugula","year":"2017","journal-title":"ACS Macro Lett"},{"key":"10.1016\/j.bioactmat.2026.02.058_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2021.02.009","article-title":"Nanoparticles that do not compete with endogenous ligands \u2013 molecular characterization in vitro, acute safety in canine, and interspecies pharmacokinetics modeling to humans","volume":"332","author":"Zou","year":"2021","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.bioactmat.2026.02.058_bib22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ijpharm.2013.04.015","article-title":"Functional benefits of PLGA particulates carrying VEGF and CoQ10 in an animal of myocardial ischemia","volume":"454","author":"Sim\u00f3n-Yarza","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"10141","key":"10.1016\/j.bioactmat.2026.02.058_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bioactmat.2026.02.058_bib24","doi-asserted-by":"crossref","first-page":"149613","DOI":"10.1016\/j.bbrc.2024.149613","article-title":"Naringenin protects against septic cardiomyopathy in mice by targeting HIF-1\u03b1","volume":"704","author":"Pan","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.02.058_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41401-020-0411-9","article-title":"Baicalin prevents LPS-induced activation of TLR4\/NF-\u03baB p65 pathway and inflammation in mice via inhibiting the expression of CD14","volume":"42","author":"Fu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.bioactmat.2026.02.058_bib26","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s11064-020-03197-7","article-title":"Suppression of TLR4\/MyD88\/TAK1\/NF-\u03baB\/COX-2 signaling pathway in the central nervous system by Bexarotene, a selective RXR agonist, prevents hyperalgesia in the lipopolysaccharide-induced pain mouse model","volume":"46","author":"Senol","year":"2021","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.02.058_bib27","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s10753-016-0483-3","article-title":"Inhibition of NLRP3 inflammasome prevents LPS-induced inflammatory hyperalgesia in mice: contribution of NF-\u03baB, Caspase-1\/11, ASC, NOX, and NOS isoforms","volume":"40","author":"Dolunay","year":"2017","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.bioactmat.2026.02.058_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/10799893.2020.1808675","article-title":"Irisin alleviates LPS-induced liver injury and inflammation through inhibition of NLRP3 inflammasome and NF-\u03baB signaling","volume":"41","author":"Li","year":"2021","journal-title":"J. Recept. Signal Transduct. Res."},{"issue":"5","key":"10.1016\/j.bioactmat.2026.02.058_bib29","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.immuni.2015.10.009","article-title":"Caspase-11 requires the Pannexin-1 channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock","volume":"43","author":"Yang","year":"2015","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.bioactmat.2026.02.058_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.tips.2019.01.001","article-title":"Intracellular lipopolysaccharide sensing as a potential therapeutic target for sepsis","volume":"40","author":"Pfalzgraff","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioactmat.2026.02.058_bib31","doi-asserted-by":"crossref","first-page":"153338","DOI":"10.1016\/j.tox.2022.153338","article-title":"Polystyrene nanoplastics exacerbate lipopolysaccharide-induced myocardial fibrosis and autophagy in mice via ROS\/TGF-\u03b21\/Smad","volume":"480","author":"Lin","year":"2022","journal-title":"Toxicology"},{"key":"10.1016\/j.bioactmat.2026.02.058_bib32","doi-asserted-by":"crossref","first-page":"1649179","DOI":"10.3389\/fonc.2025.1649179","article-title":"The pivotal role of TGF-\u03b2\/Smad pathway in fibrosis pathogenesis and treatment","volume":"15","author":"Chen","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioactmat.2026.02.058_bib33","doi-asserted-by":"crossref","first-page":"106725","DOI":"10.1016\/j.intimp.2020.106725","article-title":"Interleukin-35 pretreatment attenuates lipopolysaccharide-induced heart injury by inhibition of inflammation, apoptosis and fibrotic reactions","volume":"86","author":"Hu","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.bioactmat.2026.02.058_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24568","article-title":"Apelin ameliorates sepsis-induced myocardial dysfunction via inhibition of NLRP3-mediated pyroptosis of cardiomyocytes","volume":"10","author":"Cao","year":"2024","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.bioactmat.2026.02.058_bib35","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/08923973.2022.2073890","article-title":"Tectoridin alleviates lipopolysaccharide-induced inflammation via inhibiting TLR4-NF-\u03baB\/NLRP3 signaling in vivo and in vitro","volume":"44","author":"Niu","year":"2022","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"20","key":"10.1016\/j.bioactmat.2026.02.058_bib36","doi-asserted-by":"crossref","first-page":"10933","DOI":"10.3390\/ijms222010933","article-title":"Mechanism of phosgene-induced acute lung injury and treatment strategy","volume":"22","author":"Lu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2026.02.058_bib37","doi-asserted-by":"crossref","first-page":"917395","DOI":"10.3389\/fimmu.2022.917395","article-title":"Phosgene-induced acute lung injury: approaches for mechanism-based treatment strategies","volume":"13","author":"Cao","year":"2022","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.bioactmat.2026.02.058_bib38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2131\/jts.45.625","article-title":"NLRP3 gene silencing ameliorates phosgene-induced acute lung injury in rats by inhibiting NLRP3 inflammasome and proinflammatory factors, but not anti-inflammatory factors","volume":"45","author":"He","year":"2020","journal-title":"J. Toxicol. Sci."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26001271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26001271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:47:46Z","timestamp":1780991266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X26001271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":38,"alternative-id":["S2452199X26001271"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.02.058","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-function oral nanotherapeutic mitigates sepsis-like multi-organ failure by targeting inflammatory and fibrotic pathways","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.02.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}